Shiga University of Medical Science and Ge Medical Systems Global Technology Company | Date: 2013-10-15
A display device configured to display an endoscopic image obtained by an endoscope for observing an object is provided. The display device includes a projecting unit configured to project coordinate axes set to the object onto the endoscopic image, and a display unit configured to display thereon the endoscopic image and the coordinate axes projected onto the endoscopic image.
Shiga University of Medical Science and ORIENT MICROWAVE Corporation | Date: 2011-11-17
An object of the present invention is to provide a small-sized microwave surgical instrument that improves the convenience of surgical work. The microwave surgical instrument
Shiga University of Medical Science | Date: 2012-12-14
Provided is a surgical instrument that is substitutable for an operation of placing each stitch with a threaded needle or a stapler. It is confirmed that, in a tissue suturing device including a clamping section, and a protruding section including a central conductor and/or an external conductor for applying a microwave, the protruding section and the clamping section bring fragmentary portions of tissues to be sutured into contact or overlap with each other, and coagulate and/or fix contact or overlap portions with the microwave, to thereby stitch the tissues to be sutured.
Shiga University of Medical Science | Date: 2012-08-09
It is an object to provide a surgical instrument capable of locally applying microwaves to a minute biological tissue. It has been found that microwaves can be transmitted to a tip of a tapered coaxial body (
Shionogi & Co., Riken and Shiga University of Medical Science | Date: 2013-08-08
Disclosed are: a method for detecting (diagnosing) visceral obesity in a subject; a test agent useful for the method; a method for searching for a substance that can be used as an active ingredient for ameliorating visceral obesity; and an ameliorating agent for visceral obesity or a medicinal agent for preventing a metabolic disease developed as a result of the progression of visceral obesity. As the test agent, a polynucleotide which comprises at least 15 nucleotides and can hybridize with a nucleotide sequence for coiled-coil domain containing protein 3 (CCDC3) gene or a nucleotide sequence complementary to the nucleotide sequence under stringent conditions or an antibody capable of recognizing CCDC3 protein is used.